Skip to main content
. 2014 Jan 8;9(1):e84103. doi: 10.1371/journal.pone.0084103

Table 1. Characteristics of acute stroke patients (n = 81,143) according to preadmission antipsychotic medication use.

Characteristics Current antipsychotics users (n = 2,770, 3.41%) Former antipsychotics users (n = 6,121, 7.54%) Never antipsychotics users (n = 72,252, 89.0%)
Age Mean (SD) 71.77 (13.44) 72.40 (13.59) 71.99 (13.28)
Age, distribution, n (%) <70 years 1,148 (41.44) 2,388 (39.01) 29,012 (40.15)
≥70 years 1,622 (58.56) 3,733 (60.99) 43,240 (59.85)
Gender, n (%) Male 1,107 (39.96) 2,519 (41.15) 38,777 (53.67)
Female 1,663 (60.04) 3,602 (58.85) 33,475 (46.33)
Severity of stroke, n (%) Mild (≥45 pts) 1,095 (39.53) 2,799 (45.73) 37,489 (51.89)
Moderate (30–44 pts) 502 (18.12) 981 (16.03) 10,352 (14.33)
Severe (15–29 pts) 307 (11.08) 605 (9.88) 6,217 (8.60)
Very severe (≤14 pts) 380 (13.72) 685 (11.19) 6,825 (9.45)
Unknown 486 (17.55) 1,051 (17.17) 11,369 (15.74)
Type of stroke, n (%) Intracerebral hemorrhage 313 (11.30) 724 (11.83) 8,067 (11.17)
Ischemic 1,906 (68.81) 4,245 (69.35) 51,588 (71.40)
Unspecified 551 (19.89) 1,152 (18.82) 12,597 (17.43)
Comorbidity index, n (%)* No comorbidity, 0 1,108 (40.00) 2,476 (40.45) 37,401 (51.76)
Moderate comorbidity, 1 626 (22.60) 1,289 (21.06) 12,123 (16.78)
Severe comorbidity, 2+ 1,036 (37.40) 2,356 (38.49) 22,728 (31.46)
Former stroke, n (%) Yes 717 (25.88) 1,480 (24.18) 13,772 (19.06)
No 1,803 (65.09) 4,226 (69.04) 54,166 (74.97)
Missing 250 (9.03) 415 (6.78) 4,314 (5.97)
Education, n (%) Long 49 (1.77) 125 (2.04) 2,015 (2.79)
Medium 184 (6.64) 422 (6.89) 6,414 (8.88)
Short 605 (21.84) 1,509 (24.65) 20,596 (28.51)
High school 46 (1.66) 71 (1.16) 1,038 (1.44)
Primary school 1,397 (50.43) 2,939 (48.02) 30,368 (42.03)
Missing 489 (17.65) 1,055 (17.24) 11,821 (16.36)
Type of antipsychotics Typical 1,635 (20.80) 6,230 (79.21) 0.00 (0.00)
Atypical 1,323 (58.80) 927 (41.20) 0.00 (0.00)
Preadmission drug use Antihypertensive drug, n (%) 2,119 (76.50) 4,871 (79.58) 50,178 (69.45)
Lipid-lowering drugs, n (%) 572 (20.65) 1,562 (25.52) 17,135 (23.72)
Platelet inhibitors, n (%) 1,556 (56.17) 3,663 (59.84) 36,547 (50.58)
Antidiabetic drugs, n (%) 389 (14.04) 850 (13.89) 8,274 (11.45)
BMI, n (%) <18.5 101 (3.65) 219 (3.58) 2,149 (2.97)
18.5-<25 663 (23.94) 1,705 (27.85) 20,365 (28.19)
≥25 822 (29.68) 1,796 (29.34) 23,302 (32.25)
Missing 1,184 (42.74) 2,401 (39.23) 26,436 (36.59)
Alcohol units/week, n (%) ≤14 for women/≤ 21 for men 1,842 (66.50) 4,364 (71.30) 55,108 (76.27)
>14 for women/> 21 for men 208 (7.51) 507 (8.28) 5,068 (7.01)
Missing 720 (25.99) 1,250 (20.42) 12,076 (16.71)
Smoking habits, n (%) Never 551 (19.89) 1,528 (24.96) 20,989 (29.05)
Daily or occasionally 1,069 (38.59) 2,183 (35.66) 23,158 (32.05)
Former (>½ year) 356 (12.85) 1,005 (16.42) 14,410 (19.94)
Missing 794 (28.66) 1,405 (22.95) 13,695 (18.95)

Modified Charlson’s index (cerebrovascular disorders excluded).

Sums of proportions can exceed total number of users; some patients will appear in both categories, e.g. current use of atypical and former use of typical antipsychotics.